Cartherics is a biotechnology company focused on developing innovative therapies for cancer, endometriosis and neurological conditions such as Alzheimer’s Disease. We have developed immune killer cells (NK Cells) that are genetically modified and expanded for therapy in solid tumours such as ovarian cancer or pancreatic cancer and conditions such as endometriosis or adenomyosis.  Our primary focus is on therapies that involve gene editing stem cells made from donor umbilical cord blood and the manufacturing of immune killer cells that can be available to patients “off-the-shelf”. We also extract extracellular vesicles (EVs) for use in adjunct therapies.